Lipid nanocapsules for intracellular drug delivery of anticancer drugs. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Journal of Nanoscience and Nanotechnology Année : 2007

Lipid nanocapsules for intracellular drug delivery of anticancer drugs.

Résumé

As non-phagocytic eukaryotic cells can internalize particles < 1 microm in size, small size (25 to 110 nm) lipid nanocapsules (LNC) are proposed for the intracellular drug delivery of anticancer drugs to cancer cells. LNC of different diameters were loaded with etoposide or paclitaxel and subsequently tested for drug release kinetics and their efficiency to reduce cancer cell growth in cell culture. Relative high drug loads could be achieved and sustained drug release can be provided over a period of several days (etoposide) up to a few weeks (paclitaxel). While particle size exhibited only minor influences on the release kinetics, higher initial drug load led to a distinctly lower burst release. In a cancer cell culture model, etoposide or paclitaxel LNC showed a 4-fold or 40-fold higher efficiency, respectively than the drug solution while blank LNC were found to be less toxic than the pure drug at equivalent concentrations. The uptake and intracellular accumulation of LNC was confirmed by confocal laser scanning microscopy after fluorescence labeling of the nanocarriers. This nanoparticulate system is able to achieve efficient intracellular drug concentrations and seems to be therefore a promising therapeutic approach in cancer treatment.
Fichier non déposé

Dates et versions

inserm-00258361 , version 1 (21-02-2008)

Identifiants

  • HAL Id : inserm-00258361 , version 1
  • PUBMED : 18283853

Citer

Franck Lacoueille, Jean-Pierre Benoit, Emmanuel Garcion, Alf Lamprecht. Lipid nanocapsules for intracellular drug delivery of anticancer drugs.. Journal of Nanoscience and Nanotechnology, 2007, 7 (12), pp.4612-7. ⟨inserm-00258361⟩

Collections

INSERM UNIV-ANGERS
71 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More